{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:48Z","timestamp":1787027028034,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374297"],"award-info":[{"award-number":["82374297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"\n Background<\/jats:title>\n \n Ganoderma lucidum<\/jats:italic>\n (\n G. lucidum<\/jats:italic>\n ), which possesses various biological effects, has been widely used as traditional medicine and functional food in Asian countries, especially China. In consideration of its various biological effects on human healthcare,\n G<\/jats:italic>\n .\n lucidum<\/jats:italic>\n was usually used in combination with other drugs. However, the potential drug-drug interaction induced by\n G<\/jats:italic>\n .\n lucidum<\/jats:italic>\n through cytochrome P450 enzymes (CYPs) remain unknown.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Using the\n in vivo<\/jats:italic>\n activity assay of CYPs, the inhibitory effects of\n G. lucidum<\/jats:italic>\n and its constituents could be evaluated. The interference of\n G. lucidum<\/jats:italic>\n on the metabolic processes of clinical drugs could be investigated. The chemical constituents of\n G<\/jats:italic>\n .\n lucidum<\/jats:italic>\n could be identified using LC-MS. The interaction between bioactive compounds and CYPs could be proposed through\n in silico<\/jats:italic>\n docking analysis and molecular dynamics.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The dichloromethane extract of\n G<\/jats:italic>\n .\n lucidum<\/jats:italic>\n could inhibit various CYP450 subtypes\n in vitro<\/jats:italic>\n and interfere with the pharmacokinetics of four drugs in rats. Triterpenoids were identified as the main constituents of the dichloromethane extract by Q-TOF-MS\n n<\/jats:sup>\n in preliminary analyses. Then, a triterpenoid library containing 66 compounds was established to evaluate their inhibitory effects against CYP 1A2, 2D6, 3A4, 2A6, 2B6, 2C9, and 2C19. CYP 1A2 was inhibited by most lanostane triterpenoids, indicating a strong affinity for these compounds. Among triterpenoids, compound\n 25<\/jats:bold>\n displayed a broad inhibitory effect against CYPs, except for CYP 3A4, 2D6, 2C9, and 2C19. Finally, compounds\n 6<\/jats:bold>\n and\n 25<\/jats:bold>\n exhibited interference with the metabolism of 16 drugs through the inhibition of CYPs\n in vitro<\/jats:italic>\n . In silico molecular docking analyses for assaying the interaction between compound\n 25<\/jats:bold>\n and CYPs indicated that the hydrogen bonds formed between the hydroxyl groups and amino acid residues.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n G<\/jats:italic>\n .\n lucidum<\/jats:italic>\n displayed broad inhibitory effects on CYPs, with triterpenoids as the main bioactive constituents, which may induce potential drug-drug interaction. This information should be helpful for the rational use of\n G<\/jats:italic>\n .\n lucidum<\/jats:italic>\n in promoting human health.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fphar.2024.1485209","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T03:51:48Z","timestamp":1731642708000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Triterpenoids from Ganoderma lucidum inhibit cytochrome P450 enzymes interfering with the metabolic process of specific clinical drugs"],"prefix":"10.3389","volume":"15","author":[{"given":"Dawei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijing","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"113047","DOI":"10.1016\/j.jep.2020.113047","article-title":"Ganoderma lucidum: a rational pharmacological approach to surmount cancer","volume":"260","author":"Ahmad","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/nu15081874","article-title":"Ganoderma lucidum: novel insight into hepatoprotective potential with mechanisms of action","volume":"15","author":"Ahmad","year":"2023","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"104774","DOI":"10.1016\/j.bioorg.2021.104774","article-title":"Lucidumones B-H, racemic meroterpenoids that inhibit tumor cell migration from Ganoderma lucidum","volume":"110","author":"Cai","year":"2021","journal-title":"Bioorg. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1080\/14786419.2017.1278593","article-title":"Structural data and immunomodulatory properties of a water-soluble heteroglycan extracted from the mycelium of an Italian isolate of Ganoderma lucidum","volume":"31","author":"Carrieri","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/13880209.2021.1969413","article-title":"The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk","volume":"59","author":"Chan","year":"2021","journal-title":"Pharm. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"11216","DOI":"10.1021\/acs.analchem.2c01691","article-title":"Visual identification of trichosporon asahii, a gut Yeast associated with obesity, using an enzymatic NIR fluorescent probe","volume":"94","author":"Feng","year":"2022","journal-title":"Anal. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-981-13-9867-4_3","article-title":"Chemical components of ganoderma","volume":"1181","author":"Gong","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13020-020-00356-4","article-title":"Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review","volume":"15","author":"Lam","year":"2020","journal-title":"Chin. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14786419.2022.2078817","article-title":"Nor-triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH","volume":"37","author":"Li","year":"2023","journal-title":"Nat. Prod. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"113339","DOI":"10.1016\/j.phytochem.2022.113339","article-title":"Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH","volume":"203","author":"Li","year":"2022","journal-title":"Phytochemistry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"105161","DOI":"10.1016\/j.fitote.2022.105161","article-title":"Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH","volume":"158","author":"Lin","year":"2022","journal-title":"Fitoterapia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijbiomac.2022.12.276","article-title":"A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide","volume":"229","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B13","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"B14","doi-asserted-by":"publisher","first-page":"113255","DOI":"10.1016\/j.ejmech.2021.113255","article-title":"Discovery of a novel potent cytochrome P450 CYP4Z1 inhibitor","volume":"215","author":"Machalz","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr. Drug. Targets"},{"key":"B16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jpba.2012.10.016","article-title":"A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS\/MS","volume":"74","author":"Pillai","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/tcr.10058","article-title":"Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions","volume":"3","author":"Shiao","year":"2003","journal-title":"Chem. Rec."},{"key":"B18","doi-asserted-by":"publisher","first-page":"112256","DOI":"10.1016\/j.phytochem.2019.112256","article-title":"Lanostane triterpenoids with anti-inflammatory activities from Ganoderma lucidum","volume":"173","author":"Su","year":"2020","journal-title":"Phytochemistry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.7150\/jca.13599","article-title":"Ganoderma lucidum combined with the EGFR tyrosine kinase inhibitor, erlotinib synergize to reduce inflammatory breast cancer progression","volume":"7","author":"Su\u00e1rez-Arroyo","year":"2016","journal-title":"J. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1039\/d2fo01683d","article-title":"Therapeutic potential and nutritional significance of Ganoderma lucidum - a comprehensive review from 2010 to 2022","volume":"14","author":"Swallah","year":"2023","journal-title":"Food Funct."},{"key":"B21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2710.1998.00086.x","article-title":"Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes","volume":"23","author":"Tanaka","year":"1998","journal-title":"J. Clin. Pharm. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.crfs.2022.100427","article-title":"Modulation of gut microbiota and lipid metabolism in rats fed high-fat diets by Ganoderma lucidum triterpenoids","volume":"6","author":"Tong","year":"2023","journal-title":"Curr. Res. Food. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.apha.2018.04.007","article-title":"Cytochrome P450 in pharmacogenetics: an update","volume":"83","author":"Tornio","year":"2018","journal-title":"Adv. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1248\/bpb.30.1702","article-title":"Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats","volume":"30","author":"Wang","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"B25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1080\/10286020.2017.1367770","article-title":"Chemical characteristics of the fungus Ganoderma lucidum and their inhibitory effects on acetylcholinesterase","volume":"20","author":"Wei","year":"2018","journal-title":"J. Asian Nat. Prod. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"17478","DOI":"10.3390\/molecules191117478","article-title":"A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp","volume":"219","author":"Xia","year":"2014","journal-title":"Molecules"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29804","DOI":"10.1021\/acsomega.1c04244","article-title":"Interaction and inhibition of a Ganoderma lucidum proteoglycan on PTP1B activity for anti-diabetes","volume":"6","author":"Yu","year":"2021","journal-title":"ACS Omega"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1080\/14786410601129721","article-title":"Sterols and triterpenoids from the spores of Ganoderma lucidum","volume":"22","author":"Zhang","year":"2008","journal-title":"Nat. Prod. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1021\/acs.jnatprod.5b00132","article-title":"Inhibitory effects of highly oxygenated lanostane derivatives from the fungus Ganoderma lucidum on P-glycoprotein and alpha-glucosidase","volume":"78","author":"Zhao","year":"2015","journal-title":"J. Nat. Prod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phytol.2016.03.007","article-title":"Isolation and identification of oxygenated lanostane-type triterpenoids from the fungus Ganoderma lucidum","volume":"16","author":"Zhao","year":"2016","journal-title":"Phytochem. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1127123","DOI":"10.3389\/fphar.2023.1127123","article-title":"Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy","volume":"14","author":"Zhen","year":"2023","journal-title":"Front. Pharmacol."}],"updated-by":[{"DOI":"10.3389\/fphar.2024.1539089","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1485209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T04:14:16Z","timestamp":1734581656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1485209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":32,"alternative-id":["10.3389\/fphar.2024.1485209"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1485209","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"article-number":"1485209"}}